Could long-term arthritis treatment raise your risk of sudden hearing loss?

Imagine living with ankylosing spondylitis, a chronic arthritis that stiffens your spine and joints. For many, treatment involves taking adalimumab, a powerful biologic drug, often alongside methotrexate. A recent look at data from Henan Provincial People’s Hospital examined 2,564 patients to see if this combination therapy was connected to sudden sensorineural hearing loss, a condition where hearing drops quickly without warning. The researchers found that patients who experienced this hearing loss had lived with their arthritis for longer, had higher disease activity, and took more medication over time. These differences were statistically significant, meaning they were unlikely to be random chance. However, the study design means we cannot say the drugs caused the hearing loss. It is possible that people with more severe disease are both more likely to take these strong medicines and more likely to experience hearing issues for other reasons.